Open AccessOral colonization by Levilactobacillus brevis KABPTM-052 and Lactiplantibacillus plantarum KABPTM-051: A Randomized, Double-Blinded, Placebo-Controlled Trial (Pilot Study)
Author(s) -
José Nart,
Sara Jiménez-Garrido,
Anaïs Ramírez-Sebastià,
Erola Astó,
David Buj,
Pol Huedo,
Jordi Espadaler
Publication year - 2021
Publication title -
journal of clinical and experimental dentistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.481
H-Index - 23
ISSN - 1989-5488
DOI - 10.4317/jced.57771
Subject(s) - placebo , probiotic , medicine , saliva , lactobacillus plantarum , gingivitis , randomized controlled trial , placebo controlled study , gastroenterology , dentistry , biology , double blind , pathology , lactic acid , alternative medicine , bacteria , genetics
To determine the oral colonization capacity of the strains Levilactobacillus brevis KABPTM-052 (CECT 7480) and Lactiplantibacillus plantarum KABPTM-051 (CECT 7481) in healthy subjects.